
Please try another search
By Michael Elkins
Shares of American medical clothing company, Figs Inc (NYSE:FIGS) are up 6.05% in mid-day trading on Tuesday after Cowen raised their estimates on the stock and increased the company’s price target to $11.00 (from $6.00).
Analysts there wrote in a note “We are raising estimates above consensus sales and EPS into 2023 and 2024 based on our checks and margin recovery potential in 2H:23, though inventory +142% y/y creates uncertainty in modeling and Free Cash Flow timing through FY24. We model a path to $150MM in Free Cash Flow. Raising target to $11, which is 34x FY24E EPS, 2.6x sales.”
Management is guiding FY22 net sales to $495M with AOV pressured along with a deceleration in frequency, implying Q4:22 sales of $134M, representing +4% y/y sales growth. Cowen raised Q4 revenue estimates to +16%, which is still down from 25% growth in Q3. Q4 EPS estimate moves to $0.02 vs consensus of $0.01.
Cowen’s FY23 EPS estimate moves to $0.28 vs. the consensus of $0.15, and FY24 EPS estimates to $0.31 vs. the consensus of $0.21.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.